Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1992 1
1995 1
1997 1
1998 1
2000 2
2001 4
2002 4
2003 2
2004 1
2005 2
2006 5
2007 1
2008 2
2009 5
2010 4
2011 3
2012 5
2013 6
2014 6
2015 9
2016 8
2017 9
2018 5
2019 4
2020 7
2021 9
2022 7
2023 2
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial.
Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, Nieuwenhuijs VB, Bollen TL, van Ramshorst B, Witteman BJ, Rosman C, Ploeg RJ, Brink MA, Schaapherder AF, Dejong CH, Wahab PJ, van Laarhoven CJ, van der Harst E, van Eijck CH, Cuesta MA, Akkermans LM, Gooszen HG; Dutch Acute Pancreatitis Study Group. Besselink MG, et al. Among authors: wahab pj. Lancet. 2008 Feb 23;371(9613):651-659. doi: 10.1016/S0140-6736(08)60207-X. Epub 2008 Feb 14. Lancet. 2008. PMID: 18279948 Free article. Clinical Trial.
Intraepithelial lymphocytes and coeliac disease.
Collin P, Wahab PJ, Murray JA. Collin P, et al. Among authors: wahab pj. Best Pract Res Clin Gastroenterol. 2005 Jun;19(3):341-50. doi: 10.1016/j.bpg.2005.01.005. Best Pract Res Clin Gastroenterol. 2005. PMID: 15925840 Review.
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.
Danese S, Colombel JF, Lukas M, Gisbert JP, D'Haens G, Hayee B, Panaccione R, Kim HS, Reinisch W, Tyrrell H, Oh YS, Tole S, Chai A, Chamberlain-James K, Tang MT, Schreiber S; GARDENIA Study Group. Danese S, et al. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):118-127. doi: 10.1016/S2468-1253(21)00294-6. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798038 Free article. Clinical Trial.
On naivety of T cells in inflammatory bowel disease: a review.
Smids C, Horjus Talabur Horje CS, Wahab PJ, Groenen MJ, Middendorp S, van Lochem EG. Smids C, et al. Among authors: wahab pj. Inflamm Bowel Dis. 2015 Jan;21(1):167-72. doi: 10.1097/MIB.0000000000000221. Inflamm Bowel Dis. 2015. PMID: 25268637 Review.
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; HICKORY Study Group. Peyrin-Biroulet L, et al. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):128-140. doi: 10.1016/S2468-1253(21)00298-3. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798039 Free article. Clinical Trial.
Analysis of Intestinal T-Cell Subsets in Inflammatory Bowel Disease.
Roosenboom B, van Lochem EG, Smids C, Groenen MJM, Wahab PJ, Horjus Talabur Horje CS. Roosenboom B, et al. Among authors: wahab pj. Inflamm Bowel Dis. 2020 Jan 6;26(2):e13. doi: 10.1093/ibd/izz310. Inflamm Bowel Dis. 2020. PMID: 31904085 No abstract available.
99 results